China NT Pharma Group Company Limited (1011.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
22
First IPO Date
April 20, 2011
| Name | Title | Pay | Year Born |
| Bozhi Zhang | Chief Executive Officer | 0 | 1981 |
| Ching Mei Ng | Executive Director | 846,146 | 1999 |
| Tit Ng | Co-Founder & Executive Chairman | 846,146 | 1964 |
| Jing Fang | Chief Financial Officer | 0 | 1970 |
| Yifang Li | Company Secretary | 0 | 1991 |
China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.